Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Featured
Page 133
Featured
Featured posts
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024
ME Staff
-
November 10, 2024
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Here’s A Look at Merck’s Latest Priority Review Candidate
Roger Hannington
-
January 28, 2016
0
Here’s What to Look out for in Regulus’ Upcoming Interim Release
Roger Hannington
-
January 27, 2016
0
Movers and Shakers: The Week so Far in Biotech
Jennifer Aldershot
-
January 26, 2016
0
Zafgen is Preparing to Mount a Beloranib Defense
ME Staff
-
January 25, 2016
0
Off the Radar Dermira Targets a Billion Dollar Opportunity
Roger Hannington
-
January 22, 2016
0
Acacia Needs a Suitor; Who Fits the Bill?
-
January 21, 2016
0
Wednesday’s Movers and Shakers in Biotech
Jennifer Aldershot
-
January 20, 2016
0
The Science Behind Acorda’s Billion Dollar Market Buyout
Roger Hannington
-
January 19, 2016
0
BioMarin, Sarepta’s Loss Could Be PTC’s Gain
Roger Hannington
-
January 18, 2016
0
Vertex Eyes a Half Billion Dollar Boost with Upcoming sNDA Decision
Jennifer Aldershot
-
January 15, 2016
0
1
...
132
133
134
...
144
Page 133 of 144
